Author

Saskia Krüger

Observed names: Krüger, Saskia, S Krüger

Institution: Berlin-Chemie AG (Germany)

Observed institutions: Universität Hamburg, University Medical Center Hamburg-Eppendorf, German Centre for Cardiovascular Research, Berlin-Chemie AG (Germany)

ORCID: 0000-0002-0807-4851

Observed ORCID: 0000-0002-0807-4851

OpenAlex ID: A5047270851

Matrix metalloproteinases in coronary artery disease and myocardial infarction

2023 · Hanna Bräuninger, Saskia Krüger, et al. · Basic Research in Cardiology · 98

Precursor proadrenomedullin influences cardiomyocyte survival and local inflammation related to myocardial infarction

2018 · Svenja Hinrichs, Katharina Scherschel, et al. · Proceedings of the National Academy of Sciences · 35

Macrophage Migration Inhibitory Factor (MIF) Expression Increases during Myocardial Infarction and Supports Pro-Inflammatory Signaling in Cardiac Fibroblasts

2019 · Svenja Voss, Saskia Krüger, et al. · Biomolecules · 34

Real-World Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol Once-Daily Single-Inhaler Triple Therapy for Symptomatic COPD: The ELLITHE Non-Interventional Trial

2024 · Kai-Michael Beeh, Karl Scheithe, et al. · International Journal of COPD · 21

Clinically Important Improvements and Disease Stability with Fluticasone Furoate/Umeclidinium/Vilanterol Once-Daily Single-Inhaler Triple Therapy in the ELLITHE Trial: A Post Hoc Responder Analysis

2025 · Kai-Michael Beeh, Karl Scheithe, et al. · Pulmonary Therapy · 4

Einsatz von langwirksamen Dreifachkombinationen in der Praxis zur Therapie der chronisch-obstruktiven Lungenerkrankung (COPD) – Die ELETHON-Versorgungsstudie

2024 · Kai-Michael Beeh, Saskia Krüger · Pneumologie · 1

Clinical benefits with Fluticasone furoate/Umeclidinium/Vilanterol therapy for COPD: post hoc subgroup analysis of ELLITHE study

2024 · Kai-Michael Beeh, Saskia Krüger · European Respiratory Journal

Real-World-Daten zur Wirksamkeit der einmal täglichen Dreifachfixkombination aus Fluticasonfuroat/Umeclidinium/Vilanterol bei der Therapie der symptomatischen COPD: Die ELLITHE nichtinterventionelle Studie

2024 · K Beeh, K Scheithe, et al. · Pneumologie

Works count: 9

Citation count: 193

H-index: 4

I10-index: 4